Waystar Holding Corp.

NASDAQ:WAY

Information Technology Services

Technology
$27.54 -1.06%

-$0.19 today

Market cap
$5.30B
Beta
0.10
P/E (TTM)
27.4
EPS (TTM)
$0.66
52W Low $17.75High $41.47

Volume 1.26M

Average 2.50M

WAY Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Waystar Holding Corp.NASDAQ: WAY

Research & Development · Q2 FY2026 · quarter ended Jun 2026

Research & development grows, but more slowly than its trailing trend

Q2 FY2026 research & development of $17.72M rose 40.4% year over year, behind the +44.9% change in trailing-twelve-month research & development. Sequentially, it fell 3.5% from the prior quarter. Over 3 fiscal years it compounded at +18.5% a year.

Context

  • Research & development amounted to 5.0% of revenue in FY2025, down 0.2 pp from a year earlier.
  • Research & development increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +40.4% toward the trailing-twelve-month pace of +44.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$17.72M-3.5% QoQ
Last fiscal yearDec 2025
$54.62M+12.0% YoY
LTMJun 2026
$67.01M+44.9% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+40.4%——
1 year+12.0%——
3-year CAGR+18.5%——
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
54.62M USD
Year-over-year change
+12.0%
4-year CAGR
+17.8%

Research & Development vs competitors

How WAY compares with its peers on the latest reported figures

  • WAY's LTM Jun 2026 research & development of $67.01M is the 4th highest of the 8 companies compared; the peer median is $12.5M.
  • Its year-over-year change of +44.9% is the 3rd highest of 6, against a peer median of +10.7%.
  • Research & development amounts to 5.6% of revenue for WAY, versus a peer median of 9.1%.
WAY Competitors Peer median
Research & Development for WAY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HQYHealthEquity, Inc.LTM Jul 2026$277.96M +10.7%+10.7%20.4%
DOCSDoximity, Inc.LTM Sep 2026$154.14M +47.9%+17.7%23.3%
PHRPhreesia, Inc.LTM Apr 2026$117.98M -1.9%+10.0%23.8%
WAYWaystar Holding Corp.LTM Jun 2026$67.01M +44.9%+18.5%5.6%
SPOKSpok Holdings, Inc.LTM Mar 2026$12.5M +7.2%-3.9%9.1%
CCLDCareCloud, Inc.LTM Mar 2026$7.56M +84.3%+13.2%6.1%
EVHEvolent Health, Inc.LTM Mar 2026$0 ——0.0%
CTEVClaritev CorporationLTM Mar 2026$0 ——0.0%
Peer median (excluding WAY) $12.5M+10.7%+10.7%9.1%

Competitors are the stored peer set for WAY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue578.57M704.87M791.01M943.55M1.1B
Cost of Revenue151.77M214.89M249.77M315.73M348.16M
Gross Profit426.8M489.98M541.24M627.82M751.12M
Gross Margin73.8%69.5%68.4%66.5%68.3%
Research & Development28.34M32.81M35.33M48.78M54.62M
Selling, General & Admin162.09M184.56M187.36M268.69M306.64M
Operating Expenses366.48M400.53M399.16M504.09M501.81M
Depreciation & Amortization176.06M183.17M176.47M186.63M140.55M
EBITDA236.37M272.62M318.55M310.36M389.85M
EBITDA Margin40.9%38.7%40.3%32.9%35.5%
Operating Income60.32M89.45M142.08M123.73M249.31M
Operating Margin10.4%12.7%18.0%13.1%22.7%
Interest Income00000
Interest Expense127.01M155.33M205.92M146.27M77.54M
Other Income / Expenses(127.01M)(155.33M)(205.92M)(146.27M)(77.54M)
Income Before Tax(66.7M)(65.88M)(63.83M)(22.55M)171.76M
Pre-Tax Margin-11.5%-9.3%-8.1%-2.4%15.6%
Income Tax Expense(19.58M)(14.42M)(12.5M)(3.42M)59.67M
Net Income(47.12M)(51.46M)(51.33M)(19.13M)112.09M
Net Margin-8.1%-7.3%-6.5%-2.0%10.2%
EPS (Basic)(0.28)(0.31)(0.31)(0.13)0.63
EPS (Diluted)(0.28)(0.31)(0.31)(0.13)0.61
Weighted Avg Shares166.66M166.66M166.66M149.92M177.93M
Weighted Avg Shares (Diluted)166.66M166.66M166.66M149.92M184.78M

Waystar Holding Corp.

NASDAQ:WAY

Intrinsic Alpha fair value

Locked

Current Price

$27.54

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.